Hbk Investments L P Bristol Myers Squibb CO Put Options Transaction History

Hbk Investments L P

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $17 Million - $18.8 Million	-266,100 Reduced 95.1%	13,700 $876,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $5.24 Million - $5.95 Million	-79,800 Reduced 22.19%	279,800 $19.4 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $19.6 Million - $23.2 Million	285,800 Added 387.26%	359,600 $25.9 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $5,798 - $3.43 Million	44,600 Added 152.74%	73,800 $5.25 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $2.12 Million - $2.34 Million	29,200 New	29,200 $2.25 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.